0 NASDAQ Companies - September 24, 2020Pluralsight Announces Keynote Speakers For LIVE 2020 Virtual User ConferenceSILICON SLOPES, Utah, Sept. 24, 2020 (GLOBE NEWSWIRE) — Pluralsight, Inc. (NASDAQ: PS), the technology skills and engineering management platform, […]Read More
0 NASDAQ Companies - September 24, 2020Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-MarketBILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive […]Read More
0 NASDAQ Companies - September 24, 2020Axogen to Participate in the 75th Annual American Society for Surgery of the Hand MeetingALACHUA, Fla., Sept. 24, 2020 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative […]Read More
0 NASDAQ Companies - September 24, 2020CareDx Launches AlloCare at Virtual Transplant FestivalSOUTH SAN FRANCISCO, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]Read More
0 NASDAQ Companies - September 24, 2020HeadHunter Group PLC Announces Admission of its American Depositary Shares to Trade on the Moscow ExchangeMOSCOW, Sept. 24, 2020 (GLOBE NEWSWIRE) — HeadHunter Group PLC (Nasdaq: HHR) (the “Company”) announced today that the Moscow Exchange […]Read More
0 NASDAQ Companies - September 24, 2020MediciNova Announces Positive Clinical Results Regarding MN-166 (ibudilast) for Prevention of Chemotherapy-induced Peripheral Neuropathy Published in Cancer Chemotherapy and PharmacologyLA JOLLA, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]Read More
0 NASDAQ Companies - September 24, 2020Generation Bio to Present at the Jefferies 2020 Virtual Gene Therapy/Editing SummitCAMBRIDGE, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a […]Read More
0 NASDAQ Companies - September 24, 2020Axsome Therapeutics Presents New Data from MOMENTUM Phase 3 Trial with AXS-07 Demonstrating Rapid Onset of Action and Reduced Symptom Recurrence in the Acute Treatment of Migraine Significantly faster time to pain relief as compared to rizatriptan (p<0.001)Significantly less relapse of migraine pain as […]Read More
0 NASDAQ Companies - September 24, 2020SurveyMonkey and Tableau Launch Election Data Hub and Exclusive Polling Partnership with AxiosSAN MATEO, Calif., Sept. 24, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) and Tableau today announced an exclusive partnership with […]Read More
0 NASDAQ Companies - September 24, 2020Accolade to Announce Fiscal Second Quarter 2021 Financial ResultsSEATTLE, Sept. 24, 2020 (GLOBE NEWSWIRE) — Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better […]Read More